These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


879 related items for PubMed ID: 23277170

  • 1. Tumours associated with BAP1 mutations.
    Murali R, Wiesner T, Scolyer RA.
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
    Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH.
    J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L, Navrátilová M, Svoboda M, Házová J, Vašíčková P, Sťahlová EH, Fabian P, Schneiderová M, Macháčková E.
    Klin Onkol; 2019 Dec; 32(Supplementum2):118-122. PubMed ID: 31409087
    [Abstract] [Full Text] [Related]

  • 8. Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.
    Marušić Z, Buljan M, Busam KJ.
    J Cutan Pathol; 2015 Jun; 42(6):406-12. PubMed ID: 25902915
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A population-based analysis of germline BAP1 mutations in melanoma.
    O'Shea SJ, Robles-Espinoza CD, McLellan L, Harrigan J, Jacq X, Hewinson J, Iyer V, Merchant W, Elliott F, Harland M, Bishop DT, Newton-Bishop JA, Adams DJ.
    Hum Mol Genet; 2017 Feb 15; 26(4):717-728. PubMed ID: 28062663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations.
    Mochel MC, Piris A, Nose V, Hoang MP.
    Am J Clin Pathol; 2015 Jun 15; 143(6):901-4. PubMed ID: 25972334
    [Abstract] [Full Text] [Related]

  • 15. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
    Martorano LM, Winkelmann RR, Cebulla CM, Abdel-Rahman MH, Campbell SM.
    Int J Dermatol; 2014 Jun 15; 53(6):657-63. PubMed ID: 24697775
    [Abstract] [Full Text] [Related]

  • 16. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma.
    Shah AA, Bourne TD, Murali R.
    Pathology; 2013 Dec 15; 45(7):651-6. PubMed ID: 24247622
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma.
    Wadt K, Choi J, Chung JY, Kiilgaard J, Heegaard S, Drzewiecki KT, Trent JM, Hewitt SM, Hayward NK, Gerdes AM, Brown KM.
    Pigment Cell Melanoma Res; 2012 Nov 15; 25(6):815-8. PubMed ID: 22889334
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. BAP1-deficient and VE1-negative atypical Spitz tumor.
    Requena C, Sanz V, Nagore E, García-Casado Z, Rubio L, Guillén C, Kutzner H.
    J Cutan Pathol; 2015 Aug 15; 42(8):564-7. PubMed ID: 25953246
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.